Back to results
US 10,314,858 B2Granted
Compositions and methods of Aloe polysaccharides
AssigneeBespoke Bioscience, LLC
InventorIvan E. Danhof
Life of this patent
Estimating the term…
Abstract
The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile injectable formulation for the treatment of one or more cancers, leukemias and lymphomas, prostate cancer, breast cancer, and colon cancer, immune diseases, particularly immune related neoplasms, acquired immune deficiency syndrome, and hepatitis C.
Claims12
An injectable formulation of a polymannan extract made by a method comprising:
- the steps of:
- weighing a specified quantity of a freeze-dried aloe powder, wherein the quantity is corrected for a moisture content;
- dissolving the freeze-dried aloe powder in deionized water to form a solution;
- adding a first volume of an organic solvent to the solution to form a first mixture;
- wherein the organic solvent to the deionized water ratio is at least 2.5:1;
- allowing the first mixture to settle for at least 8 hours;
- withdrawing a specified volume of a supernatant solution from the first mixture and adding a second volume of the organic solvent to the specified volume of the supernatant solution to form a second mixture;
- centrifuging the second mixture;
- observing for a presence of a precipitate in second mixture;
- adding a third volume of the organic solvent to first mixture if any precipitate is observed in second mixture;
- decanting the supernatant of the first mixture by siphoning, wherein the decantation is done only if no precipitate is observed in the second mixture;
- filtering the precipitate from the first mixture by using a filter paper and a suction funnel under vacuum;
- and recovering the powder of the polymannan extract from the suction funnel by scraping;
- wherein the freeze-dried aloe powder comprises:
- a specified quantity of very fine polymannan extract dissolved in deionized water, wherein the composition has at least 5.91% aloe polysaccharides having a molecular weight of 6.6×104, 63.85% aloe polysaccharides having a molecular weight of 4.8×105, 2.55% aloe polysaccharides having a molecular weight of 1.0×106, and 1.32% aloe polysaccharides having a molecular weight of 2.0×106, wherein the composition comprises at least 73.63% aloe polysaccharides;
- and one or more pharmaceutical preservatives.
13 more elements
Dependencies are inferred from the claim text.